Breslin S - Search Results

1

miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O'Driscoll L. Corcoran C, et al. Among authors: breslin s. Mol Cancer. 2014 Mar 24;13:71. doi: 10.1186/1476-4598-13-71. Mol Cancer. 2014. PMID: 24655723 Free PMC article.

2

Three-dimensional cell culture: the missing link in drug discovery.

Breslin S, O'Driscoll L. Breslin S, et al. Drug Discov Today. 2013 Mar;18(5-6):240-9. doi: 10.1016/j.drudis.2012.10.003. Epub 2012 Oct 13. Drug Discov Today. 2013. PMID: 23073387 Review.

3

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.

Rani S, Corcoran C, Shiels L, Germano S, Breslin S, Madden S, McDermott MS, Browne BC, O'Donovan N, Crown J, Gogarty M, Byrne AT, O'Driscoll L. Rani S, et al. Among authors: breslin s. Cancer Res. 2014 Jul 15;74(14):3821-33. doi: 10.1158/0008-5472.CAN-13-2053. Epub 2014 May 29. Cancer Res. 2014. PMID: 24876102

4

Receptor tyrosine kinase targeting in multicellular spheroids.

Breslin S, O'Driscoll L. Breslin S, et al. Methods Mol Biol. 2015;1233:161-8. doi: 10.1007/978-1-4939-1789-1_15. Methods Mol Biol. 2015. PMID: 25319898

5

The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.

Breslin S, O'Driscoll L. Breslin S, et al. Oncotarget. 2016 Jul 19;7(29):45745-45756. doi: 10.18632/oncotarget.9935. Oncotarget. 2016. PMID: 27304190 Free PMC article.

6

Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4.

Breslin S, Lowry MC, O'Driscoll L. Breslin S, et al. Br J Cancer. 2017 Feb 28;116(5):620-625. doi: 10.1038/bjc.2016.445. Epub 2017 Feb 2. Br J Cancer. 2017. PMID: 28152547 Free PMC article.

7

Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles.

Martinez VG, O'Neill S, Salimu J, Breslin S, Clayton A, Crown J, O'Driscoll L. Martinez VG, et al. Among authors: breslin s. Oncoimmunology. 2017 Aug 11;6(12):e1362530. doi: 10.1080/2162402X.2017.1362530. eCollection 2017. Oncoimmunology. 2017. PMID: 29209569 Free PMC article.

8

Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O'Driscoll L. Corcoran C, et al. Among authors: breslin s. Mol Cancer. 2024 Oct 1;23(1):219. doi: 10.1186/s12943-024-02139-z. Mol Cancer. 2024. PMID: 39354499 Free PMC article. No abstract available.

9

Health and Equity Data to Teach the Next Generation of Public Health Leaders.

Ofrane RH, Breslin S, Levine S, Gourevitch MN, Levy M. Ofrane RH, et al. Among authors: breslin s. Public Health Rep. 2023 Nov-Dec;138(6):981-983. doi: 10.1177/00333549221143090. Epub 2023 Jan 12. Public Health Rep. 2023. PMID: 36633364 Free PMC article.

10

The Use of Thoracic Ultrasound to Predict Transudative and Exudative Pleural Effusion.

Evans PT, S Zhang R, Cao Y, Breslin S, Panebianco N, Baston CM, Dibardino DM. Evans PT, et al. Among authors: breslin s. POCUS J. 2021 Nov 23;6(2):97-102. doi: 10.24908/pocus.v6i2.15193. eCollection 2021. POCUS J. 2021. PMID: 36895667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters